CLOV Q1 2026 Earnings EPS Surges Past Estimates Stock Slides Slightly Theriva Biologics TOVX Q1 2026 Earnings Slight EPS Beat Boosts Sentiment for ClinicalStage Biotech LMND Q1 2026 Earnings Narrowing Losses Beat Expectations as Underwriting Improves Bowhead Specialty Holdings Inc Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline MLEC Q2 2025 Earnings Narrower Loss than Expected as Stock Rises MPU Q3 2023 Earnings Narrowing Losses Amid Uncertain Outlook